ISIN | LU1683288424 |
---|---|
Valorennummer | 38312204 |
Bloomberg Global ID | |
Fondsname | UBS (Lux) Digital Health Equity Fund UB USD |
Fondsanbieter |
Credit Suisse Fund Management S.A.
Zürich, Schweiz Telefon: +41 44 333 40 50 E-Mail: clientservices.amfunds@credit-suisse.com Web: www.credit-suisse.com |
Fondsanbieter | Credit Suisse Fund Management S.A. |
Vertreter in der Schweiz |
UBS Fund Management (Switzerland) AG Basel Telefon: +41 61 288 49 10 |
Distributor(en) |
UBS AG Basel Telefon: +41 61 288 75 01 |
Anlagekategorie | Aktienfonds |
EFC-Kategorie | |
Anteilskategorie | Accumulation |
Domizilland | Luxemburg |
Konditionen bei der Ausgabe | Ausgabekommission zugunsten der Fondsleitung und/oder des Vertriebsträgers (kann bei gleichem Fonds je nach Vertriebskanal unterschiedlich sein) |
Konditionen bei der Rücknahme | Rücknahmekommission zugunsten der Fondsleitung und/oder des Vertriebsträgers (kann bei gleichem Fonds je nach Vertriebskanal unterschiedlich sein) |
Investment-Strategie *** | The objective of the Subfund is to achieve the highest possible return in US dollars (Reference Currency), while taking due account of the principle of risk diversification, the security of the capital invested, and the liquidity of the assets. This Subfund aims to outperform the return of the MSCI World ESG Leaders (NR) benchmark. The Subfund is actively managed. The benchmark is used as a reference point for portfolio construction and as a basis for setting risk constraints, and/or for Performance Fee measurement purposes. The majority of the Subfund’s equity securities will not necessarily be components of or have weightings derived from the benchmark. The Investment Manager will use its discretion to significantly deviate the weighting of certain components of the benchmark and to significantly invest in companies or sectors not included in the benchmark in order to take advantage of specific investment opportunities. |
Besonderheiten |
Aktueller Preis * | 142.58 USD | 04.11.2024 |
---|---|---|
Vorheriger Preis * | 139.21 USD | 31.10.2024 |
52 Wochen Hoch * | 153.94 USD | 27.02.2024 |
52 Wochen Tief * | 112.93 USD | 10.11.2023 |
NAV * | 142.58 USD | 04.11.2024 |
Ausgabepreis * | ||
Rücknahmepreis * | ||
Schlusskurs * | ||
Indikativer Minimalpreis | ||
Fondsvermögen *** | 1'001'210'494 | |
Anteilsklassevermögen *** | 92'926'817 | |
Trading Information SIX |
YTD-Performance | -2.13% |
29.12.2023 - 04.11.2024
29.12.2023 04.11.2024 |
---|---|---|
YTD-Performance (in CHF) | +0.52% |
29.12.2023 - 04.11.2024
29.12.2023 04.11.2024 |
1 Monat | -0.99% |
04.10.2024 - 04.11.2024
04.10.2024 04.11.2024 |
3 Monate | +8.43% |
05.08.2024 - 04.11.2024
05.08.2024 04.11.2024 |
6 Monate | +1.37% |
06.05.2024 - 04.11.2024
06.05.2024 04.11.2024 |
1 Jahr | +21.22% |
06.11.2023 - 04.11.2024
06.11.2023 04.11.2024 |
2 Jahre | +7.04% |
04.11.2022 - 04.11.2024
04.11.2022 04.11.2024 |
3 Jahre | -42.87% |
04.11.2021 - 04.11.2024
04.11.2021 04.11.2024 |
5 Jahre | +14.18% |
04.11.2019 - 04.11.2024
04.11.2019 04.11.2024 |
Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Zai Lab Ltd Ordinary Shares | 4.35% | |
---|---|---|
Veeva Systems Inc Class A | 4.04% | |
Zealand Pharma AS | 4.00% | |
TransMedics Group Inc | 3.94% | |
Redcare Pharmacy NV | 3.87% | |
Natera Inc | 3.80% | |
Schrodinger Inc Ordinary Shares | 3.65% | |
Exact Sciences Corp | 3.64% | |
Inspire Medical Systems Inc | 3.59% | |
10x Genomics Inc Ordinary Shares - Class A | 3.45% | |
Letzte Daten-Aktualisierung | 31.08.2024 |
TER | 1.15% |
---|---|
Datum TER | 31.05.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.50% |
Ongoing Charges *** | 1.15% |
SRRI ***
|
|
Datum SRRI *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |